Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Start-ups

Genentech invests in UK life sciences accelerator

by Rick Mullin
April 26, 2019 | A version of this story appeared in Volume 97, Issue 17

 

Genentech is among the investors in an accelerator aimed at funding life science and health-care start-ups. Start Codon, based in Cambridge, England, will provide seed funding up to $325,000, lab space, and support from regional research facilities to start-ups preparing for series A fundraising. Start Codon intends to support up to 50 new companies over the next 5 years. Other investors include Cambridge Innovation Capital and Babraham Bioscience Technologies.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.